There are currently five (5) incentive programs in Neola Medical.
- Warrants 2021/2025A (for senior executives, other employees and consultants in the Company) that was decided at the Annual General Meeting on May 20, 2021. During the exercise period, which runs from and including 2 June 2025 to and including 30 June 2025, these may be used for subscription of newly issued shares in the Company.
- Warrants 2021/2025B (for board members) that was decided at the Annual General Meeting on May 20, 2021. During the exercise period, which runs from and including 2 June 2025 to and including 30 June 2025, these may be used for subscription of newly issued shares in the Company.
- LTI 2022/2026 (for chief executive officer) that was decided at the Extra General Meeting on September 27, 2022. The incentive programme will run for a period of four full financial years, i.e. from January 1 to December 31, during 2022 – 2025.
- Warrants 2023/2027A (for senior executives, other employees and consultants in the Company) that was decided at the Annual General Meeting on May 17, 2023. During the exercise period, which runs from and including 1 June 2027 to and including 30 June 2027, these may be used for subscription of newly issued shares in the Company.
- Warrants 2023/2027B (for board members) that was decided at the Annual General Meeting on May 17, 2023. During the exercise period, which runs from and including 1 June 2027 to and including 30 June 2027, these may be used for subscription of newly issued shares in the Company.
